Lalwani Narendra D. 4
4 · Esperion Therapeutics, Inc. · Filed Jan 3, 2018
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-02+36,000→ 36,000 totalExercise: $66.50Exp: 2028-01-02→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2018.